Litchman Manuel MD 4
4 · MUSTANG BIO, INC. · Filed Jul 7, 2023
Insider Transaction Report
Form 4
Litchman Manuel MD
DirectorPresident, CEO and Interim CFO
Transactions
- Award
COMMON STOCK, PAR VALUE $0.0001
2023-04-24+5,000→ 111,079 total
Footnotes (3)
- [F1]Represents an award of 5,000 restricted stock units that will vest in four annual installments after the grant date, vesting in full on April 24, 2027.
- [F2]Effective April 3, 2023, the Issuer effected a fifteen-for-one reverse stock split of its common stock (the "Reverse Stock Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split.
- [F3]Includes restricted share units, which vest over various time periods.